Laurel Wealth Advisors, Inc. Abbott Laboratories Transaction History

Laurel Wealth Advisors, Inc.

$1.01 Billion
Q4 2022

A detailed history of Laurel Wealth Advisors, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Laurel Wealth Advisors, Inc. holds 19,458 shares of ABT stock, worth $2.29 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

19,458

Previous 21,947 11.34%

Holding current value

$2.29 Million

Previous $2.12 Million 0.61%

% of portfolio

0.21%

Previous 0.23%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$95.06 - $111.52 $236,604 - $277,573	-2,489 Reduced 11.34%	19,458 $2.14 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $119,498 - $138,357	1,235 Added 5.96%	21,947 $2.12 Million
Q2 2022 Aug 12, 2022	SELL	$102.07 - $123.37 $525,456 - $635,108	-5,148 Reduced 19.91%	20,712 $2.25 Million
Q1 2022 May 13, 2022	SELL	$114.02 - $139.04 $154,155 - $187,982	-1,352 Reduced 4.97%	25,860 $3.06 Million
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $1.87 Million - $2.29 Million	16,203 Added 147.18%	27,212 $3.83 Million
Q3 2021 Nov 12, 2021	SELL	$116.66 - $129.06 $153,757 - $170,101	-1,318 Reduced 10.69%	11,009 $1.3 Million
Q2 2021 Aug 16, 2021	BUY	$105.79 - $124.53 $93,412 - $109,959	883 Added 7.72%	12,327 $1.43 Million
Q1 2021 May 14, 2021	BUY	$108.84 - $128.23 $67,263 - $79,246	618 Added 5.71%	11,444 $1.37 Million
Q4 2020 Mar 03, 2021	SELL	$105.0 - $114.42 $525 - $572	-5 Reduced 0.05%	10,826 $1.19 Million
Q3 2020 Nov 13, 2020	BUY	$91.64 - $111.29 $824 - $1,001	9 Added 0.08%	10,831 $1.18 Million
Q2 2020 Aug 14, 2020	SELL	$76.57 - $98.0 $42,113 - $53,900	-550 Reduced 4.84%	10,822 $990,000
Q1 2020 May 15, 2020	BUY	$62.82 - $91.86 $41,775 - $61,086	665 Added 6.21%	11,372 $898,000
Q4 2019 Feb 13, 2020	SELL	$78.51 - $87.4 $381,872 - $425,113	-4,864 Reduced 31.24%	10,707 $930,000
Q3 2019 Nov 13, 2019	BUY	$81.84 - $88.74 $467,633 - $507,060	5,714 Added 57.97%	15,571 $1.3 Million
Q2 2019 Aug 13, 2019	BUY	$72.88 - $85.0 $10,932 - $12,750	150 Added 1.55%	9,857 $829,000
Q1 2019 May 16, 2019	BUY	$66.22 - $80.06 $48,473 - $58,603	732 Added 8.16%	9,707 $776,000
Q4 2018 Feb 13, 2019	SELL	$65.56 - $74.27 $82,998 - $94,025	-1,266 Reduced 12.36%	8,975 $649,000
Q3 2018 Nov 15, 2018	SELL	$60.81 - $73.36 $73,458 - $88,618	-1,208 Reduced 10.55%	10,241 $751,000
Q2 2018 Aug 20, 2018	BUY	$57.57 - $63.54 $1,496 - $1,652	26 Added 0.23%	11,449 $698,000
Q1 2018 May 16, 2018	SELL	$56.27 - $63.62 $9,228 - $10,433	-164 Reduced 1.42%	11,423 $684,000
Q4 2017 Feb 15, 2018	BUY	$53.68 - $57.47 $173,976 - $186,260	3,241 Added 38.83%	11,587 $661,000
Q3 2017 Nov 14, 2017	SELL	$48.06 - $53.64 $188,347 - $210,215	-3,919 Reduced 31.95%	8,346 $445,000
Q2 2017 Aug 15, 2017	BUY	N/A	12,265	12,265 $596,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurel Wealth Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Laurel Wealth Advisors, Inc. with notifications on news.

Account

Laurel Wealth Advisors, Inc. Abbott Laboratories Transaction History